The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2Angelos Hatzakis, E. Nurmukhametova, Kieron Barclay et al.|Journal of Viral Hepatitis|2015Cited by 125
Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2V A Saraswat, N. Mamonova, Suzanne Norris et al.|Journal of Viral Hepatitis|2015Cited by 93
Hyaluronic acid concentration in liver diseasesMonika Gudowska-Sawczuk, Lech Chrostek, Ewa Gruszewska et al.|Clinical and Experimental Medicine|2015Cited by 47
Galectin-3 Concentration in Liver Diseases.Monika Gudowska-Sawczuk, Lech Chrostek, Ewa Gruszewska et al.|PubMed|2015Cited by 43
Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseasesMonika Gudowska-Sawczuk, Lech Chrostek, Alicja Wrona et al.|Scandinavian Journal of Clinical and Laboratory Investigation|2017Cited by 20